Arab & Middle East News
(ARABNEWSWIRE.COM, August 07, 2018 ) Market Overview:
Anatomic Pathology market is valued at around USD 18.24 billion in 2018 and is anticipated to be developing at a CAGR of 6.1%, to attain USD 24.52 billion by 2023. Anatomical pathology is a medical specialty that is concerned about the prognosis of illnesses primarily based mostly on the macroscopic, microscopic, biochemical, immunologic and molecular examination of organs and tissues. Anatomic pathology serves to locate abnormalities by detection of numerous illnesses and is helpful in the process of treatments.
Request Report Sample: https://www.marketdataforecast.com/market-reports/anatomy-pathology-market-3337/request-sample
Rise in the prevalence of chronic diseases across the world is a key driver for the growth of the market Factors affecting market growth:
• Increasing healthcare expenditure (+)
• Rise in the prevalence of the chronic diseases across the world (+)
• Growing geriatric population coupled with increasing number of various diseases (+)
• Growing demand for customized medication and supportive repayment situation (+)
• Changing lifestyle of people (+)
• Constant reimbursement pressure (-)
• Lack of skilled professionals (-)
Get your customized report: https://www.marketdataforecast.com/market-reports/anatomy-pathology-market-3337/customize-report
Asia Pacific is predicted to grow at a rapid pace in the market
The Global Anatomic Pathology market is geographically segmented into
• North America
• Asia Pacific
• Latin America
• Middle East and Africa
The market is dominating by North America, with a market share of over 44.8% globally in 2018. The Asia Pacific is expected to develop at a fast tempo in the coming few years. North America and Europe are expected to dominate the anatomic pathology market over the forecast period, due to the presence of diverse anatomic pathology institutions and diagnostic laboratories.
Browse full Table of Contents: https://www.marketdataforecast.com/market-reports/anatomy-pathology-market-3337/
The leading companies dominating the market include Thermo Fisher Scientific (U.S.), F. Hoffmann-La Roche AG (Switzerland), Quest Diagnostics Incorporated (U.S.), Laboratory Corporation of America Holdings (U.S.), and NeoGenomics Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Sakura Finetechnical Co., Ltd. (Japan).
Name: Mr. Abhishek Shukla
Address:2nd Floor, Above ICICI Bank,B-44, Rd Number 3, Journalist Colony, Film Nagar, Hyderabad, Telangana 500033, India.
Market Data Forecast.